275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2022. Parexel International Corporation.
275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2022. Parexel International Corporation.
The biopharmaceutical industry posted record levels of VC funding in 2020 and 2021, presenting a clear opportunity for small and emerging biotechs to advance their innovations. Whether a company seeks to out-license an asset, commercialize an asset, or position itself for acquisition, success often depends on early investments. Importantly, securing investment drives the development of new treatments for the patients who need them most.
How can biotech companies plan their early development strategy to best position themselves for investment? Using both data from our investor survey and direct experience helping biotech clients, we identified five strategies that can help raise funds in the early stages of development.
Download the report by completing the short form below:
We are always available for a conversation.